Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Hum Genet ; 31(5): 596-601, 2023 05.
Article in English | MEDLINE | ID: mdl-36599937

ABSTRACT

Pathogenic variants in TGFBR1 are a common cause of Loeys-Dietz syndrome (LDS) characterized by life-threatening aortic and arterial disease. Generally, these are missense changes in highly conserved amino acids in the serine-threonine kinase domain. Conversely, nonsense, frameshift, or specific missense changes in the ligand-binding extracellular domain cause multiple self-healing squamous epithelioma (MSSE) lacking the cardiovascular phenotype. Here, we report on two novel variants in the penultimate exon 8 of TGFBR1 were identified in 3 patients from two unrelated LDS families: both were predicted to cause frameshift and premature stop codons (Gln448Profs*15 and Cys446Asnfs*4) resulting in truncated TGFBR1 proteins lacking the last 43 and 56 amino acid residues, respectively. These were classified as variants of uncertain significance based on current criteria. Transcript expression analyses revealed both mutant alleles escaped nonsense-mediated mRNA decay. Functional characterization in patient's dermal fibroblasts showed paradoxically enhanced TGFß signaling, as observed for pathogenic missense TGFBR1 changes causative of LDS. In summary, we expanded the allelic repertoire of LDS-associated TGFBR1 variants to include truncating variants escaping nonsense-mediated mRNA decay. Our data highlight the importance of functional studies in variants interpretation for correct clinical diagnosis.


Subject(s)
Loeys-Dietz Syndrome , Humans , Exons , Loeys-Dietz Syndrome/genetics , Loeys-Dietz Syndrome/pathology , Nonsense Mediated mRNA Decay , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Receptor, Transforming Growth Factor-beta Type I/genetics , Receptor, Transforming Growth Factor-beta Type I/metabolism
2.
Biol Direct ; 17(1): 8, 2022 04 28.
Article in English | MEDLINE | ID: mdl-35484629

ABSTRACT

Migrasomes, released by migrating cells, belong to the heterogeneous world of extracellular vesicles (EVs). However, they can be distinguished from all other members of EVs by their size, biorigin and protein cargo. As far as we know, they can play important roles in various communication processes, by mediating the release of signals, such as mRNAs, proteins or damaged mitochondria. To extend and better understand the functional roles and importance of migrasomes, it is first essential to well understand the basic molecular mechanisms behind their formation and function. Herein, we endeavor to provide a brief and up-to-date description of migrasome biogenesis, release, characterization, biological properties and functional activities in cell-to-cell communication, and we will discuss and propose putative new functions for these vesicles.


Subject(s)
Extracellular Vesicles , Extracellular Vesicles/metabolism , Organelles , Proteins/metabolism
3.
Methods Mol Biol ; 2310: 287-299, 2021.
Article in English | MEDLINE | ID: mdl-34096009

ABSTRACT

The dynamism of mitochondria, considered as complex and motile organelles, is brought about by mitochondria ability to undergo cycles of fission and fusion events, whose fine balance determines their morphology in a specific physiological context. A huge body of evidence makes it possible to associate mitochondrial organization to regulation of an increasing number of key cellular processes, such as biosynthetic pathways, oxidative phosphorylation and ATP production, calcium buffering, mtDNA homeostasis, autophagy, and cell death. Here, we review the recently developed imaging methods for studying mitochondrial dynamics, including live-cell imaging, by using mitochondrial-targeted fluorescent proteins. In more details, we focus our attention on two different protocols in the T cell model, an example of nonadherent cells, which present some particularities and difficulties in the analysis of mitochondrial shape. Also, we discuss some examples of mouse models carrying mitochondria-targeted fluorescent proteins, which allow to investigate the mitochondrial morphology in vivo.


Subject(s)
Microscopy, Confocal , Microscopy, Fluorescence , Mitochondria/metabolism , Mitochondrial Dynamics , T-Lymphocytes/metabolism , Animals , Cell Fractionation , Fluorescent Dyes/metabolism , Humans , Jurkat Cells , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mice, Transgenic , Microscopy, Video , Mitochondria/genetics , Mitochondria/immunology , T-Lymphocytes/immunology , Time Factors , Time-Lapse Imaging
5.
Cell Death Differ ; 27(10): 2749-2767, 2020 10.
Article in English | MEDLINE | ID: mdl-32346136

ABSTRACT

The Activation-Induced Cell Death (AICD) is a stimulation-dependent form of apoptosis used by the organism to shutdown T-cell response once the source of inflammation has been eliminated, while allowing the generation of immune memory. AICD is thought to progress through the activation of the extrinsic Fas/FasL pathway of cell death, leading to cytochrome-C release through caspase-8 and Bid activation. We recently described that, early upon AICD induction, mitochondria undergo structural alterations, which are required to promote cytochrome-C release and execute cell death. Here, we found that such alterations do not depend on the Fas/FasL pathway, which is instead only lately activated to amplify the cell death cascade. Instead, such alterations are primarily dependent on the MAPK proteins JNK1 and ERK1/2, which, in turn, regulate the activity of the pro-fission protein Drp1 and the pro-apoptotic factor Bim. The latter regulates cristae disassembly and cooperate with Drp1 to mediate the Mitochondrial Outer Membrane Permeabilization (MOMP), leading to cytochrome-C release. Interestingly, we found that Bim is also downregulated in T-cell Acute Lymphoblastic Leukemia (T-ALL) cells, this alteration favouring their escape from AICD-mediated control.


Subject(s)
Dynamins/metabolism , Mitochondria/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma , T-Lymphocytes/immunology , Animals , Cell Death , Cell Line, Tumor , Female , Humans , Lymphocyte Activation , MAP Kinase Signaling System , Male , Mice , Mice, Inbred C57BL , Mitochondrial Membranes/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , T-Lymphocytes/cytology
SELECTION OF CITATIONS
SEARCH DETAIL